On Tuesday, Abeona Therapeutics Inc (NASDAQ: ABEO) opened lower -9.27% from the last session, before settling in for the closing price of $5.61. Price fluctuations for ABEO have ranged from $3.05 to $9.01 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 6.16%. Company’s average yearly earnings per share was noted 34.86% at the time writing. With a float of $39.36 million, this company’s outstanding shares have now reached $43.40 million.
The extent of productivity of a business whose workforce counts for 84 workers is very important to gauge. In terms of profitability, gross margin is -10.2%, operating margin of -2151.13%, and the pretax margin is -2515.3%.
Abeona Therapeutics Inc (ABEO) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Abeona Therapeutics Inc is 9.47%, while institutional ownership is 61.85%. The most recent insider transaction that took place on Jun 18 ’24, was worth 116,764. In this transaction Director of this company sold 25,890 shares at a rate of $4.51, taking the stock ownership to the 36,926 shares. Before that another transaction happened on Jun 18 ’24, when Company’s Director sold 25,821 for $4.51, making the entire transaction worth $116,453. This insider now owns 62,063 shares in total.
Abeona Therapeutics Inc (ABEO) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 34.86% per share during the next fiscal year.
Abeona Therapeutics Inc (NASDAQ: ABEO) Trading Performance Indicators
Check out the current performance indicators for Abeona Therapeutics Inc (ABEO). In the past quarter, the stock posted a quick ratio of 6.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.70, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.19 in one year’s time.
Technical Analysis of Abeona Therapeutics Inc (ABEO)
The latest stats from [Abeona Therapeutics Inc, ABEO] show that its last 5-days average volume of 0.33 million was inferior to 0.33 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 17.47%. Additionally, its Average True Range was 0.27.
During the past 100 days, Abeona Therapeutics Inc’s (ABEO) raw stochastic average was set at 2.31%, which indicates a significant decrease from 3.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.72% in the past 14 days, which was higher than the 43.73% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.95, while its 200-day Moving Average is $5.51. Now, the first resistance to watch is $5.48. This is followed by the second major resistance level at $5.88. The third major resistance level sits at $6.09. If the price goes on to break the first support level at $4.87, it is likely to go to the next support level at $4.66. Assuming the price breaks the second support level, the third support level stands at $4.26.
Abeona Therapeutics Inc (NASDAQ: ABEO) Key Stats
There are currently 43,471K shares outstanding in the company with a market cap of 221.27 million. Presently, the company’s annual sales total 3,500 K according to its annual income of -54,190 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -30,270 K.
